Continuous Nerve Block for Post-Knee Replacement Pain
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are using chronic opioids equivalent to 30mg of morphine daily, you would not be eligible to participate.
What data supports the effectiveness of the treatment Continuous adductor canal block (CACB) for post-knee replacement pain?
Is continuous adductor canal block (CACB) safe for humans?
How is the continuous adductor canal block treatment different from other treatments for post-knee replacement pain?
Continuous adductor canal block (CACB) is unique because it provides ongoing pain relief by continuously delivering medication near the saphenous nerve, unlike single-injection methods that offer temporary relief. This approach can improve pain management and mobility after knee replacement surgery compared to other nerve block techniques.12378
What is the purpose of this trial?
Total knee arthroplasty (TKA) is a frequent performed surgery. Many institutions are implementing outpatient programs for this surgery and adequate pain management is an important feature. Analgesic duration of single shot nerve blocks is limited to no more than 24h. Conversely, the use of continuous nerve block (CNB) through a perineural catheter and infusion of local anesthetic may increase duration of analgesia and provide better outcomes. The purpose of this study is to evaluate effectiveness and safety of using CNB in patients undergoing primary TKA, and its effects on patients' quality of recovery. We hypothesize that continuous adductor canal block would lead to a better quality of recovery in patients undergoing primary TKA.
Research Team
Naveed Siddiqui, MD, MSc
Principal Investigator
University of Toronto
Eligibility Criteria
This trial is for patients over 21 years old who are having knee replacement surgery as outpatients and have a moderate risk of complications (ASA I-III). They should not be dependent on alcohol or drugs, understand the treatment process, and cannot be using strong painkillers regularly. People with allergies to study meds, blood clotting issues, low platelet counts, or problems where the catheter goes can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-surgery Assessment
Pre anesthesia consult and study explanation, including consent form review
Treatment
Patients undergo total knee arthroplasty with continuous adductor canal block or sham block
Follow-up
Participants are monitored for catheter associated complications and quality of recovery
Treatment Details
Interventions
- Continuous adductor canal block (CACB)
- Sham continuous adductor canal block (ShACB)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor
MOUNT SINAI HOSPITAL
Collaborator